James H McMahon
James H McMahon
Alfred Hospital, Monash University, Monash Medical Centre
Verified email at monash.edu
TitleCited byYear
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy
JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ...
PLoS pathogens 10 (11), 2014
3162014
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring
JH McMahon, MR Jordan, K Kelley, S Bertagnolio, SY Hong, CA Wanke, ...
Clinical Infectious Diseases, ciq167, 2011
1402011
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
JH Elliott, JH McMahon, CC Chang, SA Lee, W Hartogensis, N Bumpus, ...
The lancet HIV 2 (12), e520-e529, 2015
1242015
Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis
TS Boender, KCE Sigaloff, JH McMahon, S Kiertiburanakul, MR Jordan, ...
Clinical Infectious Diseases 61 (9), 1453-1461, 2015
982015
Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review
JH McMahon, JH Elliott, S Bertagnolio, R Kubiak, MR Jordan
Bulletin of the World Health Organization 91, 377-385, 2013
942013
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
912019
The HIV care cascade: a systematic review of data sources, methodology and comparability
NA Medland, JH McMahon, EPF Chow, JH Elliott, JF Hoy, CK Fairley
Journal of the International AIDS Society 18 (1), 20634, 2015
762015
Poverty, hunger, education, and residential status impact survival in HIV
J McMahon, C Wanke, N Terrin, S Skinner, T Knox
AIDS and Behavior 15 (7), 1503-1511, 2011
632011
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority …
JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ...
The lancet HIV 5 (5), e211-e220, 2018
612018
HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 …
DE Bennett, MR Jordan, S Bertagnolio, SY Hong, G Ravasi, JH McMahon, ...
Clinical infectious diseases 54 (suppl_4), S280-S289, 2012
602012
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004–2011
MR Jordan, DE Bennett, MA Wainberg, D Havlir, S Hammer, C Yang, ...
Clinical infectious diseases 54 (suppl_4), S245-S249, 2012
582012
Broad activation of latent HIV-1 in vivo
K Barton, B Hiener, A Winckelmann, TA Rasmussen, W Shao, K Byth, ...
Nature communications 7 (1), 1-8, 2016
462016
Repeated assessments of food security predict CD4 change in the setting of antiretroviral therapy
JH McMahon, CA Wanke, JH Elliott, S Skinner, AM Tang
Journal of acquired immune deficiency syndromes (1999) 58 (1), 60, 2011
442011
Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review
JH McMahon, JH Elliott, SY Hong, S Bertagnolio, MR Jordan
PLoS One 8 (2), 2013
342013
Barriers and strategies to achieve a cure for HIV
MC Pitman, JSY Lau, JH McMahon, SR Lewin
The Lancet HIV 5 (6), e317-e328, 2018
272018
The safety and effect of multiple doses of vorinostat on HIV transcription in HIV-infected patients receiving combination antiretroviral therapy
J Elliott, A Solomon, F Wightman, M Smith, S Palmer, M Prince, J Watson, ...
Conference on Retroviruses and Opportunistic Infections, 3-6, 2013
272013
Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India
JH McMahon, A Manoharan, CA Wanke, S Mammen, H Jose, T Malini, ...
AIDS and Behavior 17 (6), 2253-2259, 2013
252013
Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?
JH McMahon, JM O'keeffe, Victorian HITH Outcomes Study Group, ...
Scandinavian journal of infectious diseases 40 (1), 40-43, 2008
252008
Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy
KJ Siefried, L Mao, LA Cysique, J Rule, ML Giles, DE Smith, J McMahon, ...
AIDS (London, England) 32 (1), 35, 2018
222018
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a …
P Cahn, R Kaplan, PE Sax, K Squires, JM Molina, A Avihingsanon, ...
The Lancet HIV 4 (11), e486-e494, 2017
222017
The system can't perform the operation now. Try again later.
Articles 1–20